share_log

復星醫藥:(1)延長建議復宏漢霖上市授權有效期及更換授權人士 (2)選舉執行董事及臨時股東大會通告

FOSUN PHARMA: (1) EXTENSION OF AUTHORISATION PERIOD AND CHANGE OF AUTHORISED PERSON FOR THE PROPOSED SHANGHAI HENLIUS LISTING (2) ELECTION OF EXECUTIVE DIRECTORS AND NOTICE OF EGM

Nov 16, 2021 03:54
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more